메뉴 건너뛰기




Volumn 126, Issue 5, 2010, Pages 1144-1154

Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis

Author keywords

Endometrial cancer; mTOR pathway; Paclitaxel; Rapamycin; Telomerase

Indexed keywords

INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PACLITAXEL; PROTEIN S6; RAPAMYCIN; TELOMERASE; TUBULIN;

EID: 74049128836     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24837     Document Type: Article
Times cited : (70)

References (46)
  • 2
    • 34347220473 scopus 로고    scopus 로고
    • Defining the role of mTOR in cancer
    • Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell 2007;12:9-22.
    • (2007) Cancer Cell , vol.12 , pp. 9-22
    • Guertin, D.A.1    Sabatini, D.M.2
  • 4
    • 2342483301 scopus 로고    scopus 로고
    • Rapamycin inhibits telomerase activity by decreasing the hTERT mRNA level in endometrial cancer cells
    • Zhou C, Gehrig PA, Whang YE, Boggess JF. Rapamycin inhibits telomerase activity by decreasing the hTERT mRNA level in endometrial cancer cells. Mol Cancer Ther 2003;2:789-95.
    • (2003) Mol Cancer Ther , vol.2 , pp. 789-795
    • Zhou, C.1    Gehrig, P.A.2    Whang, Y.E.3    Boggess, J.F.4
  • 5
    • 0031833563 scopus 로고    scopus 로고
    • Mammalian target of rapamycin: Immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling
    • Abraham RT. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. Curr Opin Immunol 1998;10:330-6.
    • (1998) Curr Opin Immunol , vol.10 , pp. 330-336
    • Abraham, R.T.1
  • 7
    • 34447530619 scopus 로고    scopus 로고
    • The mammalian target of rapamycin pathway as a potential target for cancer chemoprevention
    • Kopelovich L, Fay JR, Sigman CC, Crowell JA. The mammalian target of rapamycin pathway as a potential target for cancer chemoprevention. Cancer Epidemiol Biomarkers Prev 2007;16:1330-40.
    • (2007) Cancer Epidemiol Biomarkers Prev , vol.16 , pp. 1330-1340
    • Kopelovich, L.1    Fay, J.R.2    Sigman, C.C.3    Crowell, J.A.4
  • 8
    • 14944385644 scopus 로고    scopus 로고
    • Immunohistochemical expression of E-cadherin and β-catenin in the normal and malignant human endometrium: An inverse correlation between E-cadherin and nuclear β-catenin expression
    • Shih HC, Shiozawa T, Miyamoto T, Kashima H, Feng YZ, Kurai M, Konishi I. Immunohistochemical expression of E-cadherin and β-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear β-catenin expression. Anticancer Res 2004;24:3843-50.
    • (2004) Anticancer Res , vol.24 , pp. 3843-3850
    • Shih, H.C.1    Shiozawa, T.2    Miyamoto, T.3    Kashima, H.4    Feng, Y.Z.5    Kurai, M.6    Konishi, I.7
  • 11
    • 6044259204 scopus 로고    scopus 로고
    • Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells
    • Mondesire WH, Jian W, Zhang H, Ensor J, Hung MC, Mills GB, Meric-Bernstam F. Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells. Clin Cancer Res 2004;10:7031-42.
    • (2004) Clin Cancer Res , vol.10 , pp. 7031-7042
    • Mondesire, W.H.1    Jian, W.2    Zhang, H.3    Ensor, J.4    Hung, M.C.5    Mills, G.B.6    Meric-Bernstam, F.7
  • 13
    • 33646197484 scopus 로고    scopus 로고
    • Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel
    • Faried LS, Faried A, Kanuma T, Nakazato T, Tamura T, Kuwano H, Minegishi T. Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel. Eur J Cancer 2006;42:934-47.
    • (2006) Eur J Cancer , vol.42 , pp. 934-947
    • Faried, L.S.1    Faried, A.2    Kanuma, T.3    Nakazato, T.4    Tamura, T.5    Kuwano, H.6    Minegishi, T.7
  • 14
    • 0035866358 scopus 로고    scopus 로고
    • Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy
    • Geoerger B, Kerr K, Tang CB, Fung KM, Powell B, Sutton LN, Phillips PC, Janss AJ. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy. Cancer Res 2001;61:1527-32.
    • (2001) Cancer Res , vol.61 , pp. 1527-1532
    • Geoerger, B.1    Kerr, K.2    Tang, C.B.3    Fung, K.M.4    Powell, B.5    Sutton, L.N.6    Phillips, P.C.7    Janss, A.J.8
  • 15
    • 0032006059 scopus 로고    scopus 로고
    • Microtubules and actin filaments: Dynamic targets for cancer chemotherapy
    • Jordan MA, Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 1998;10:123-30.
    • (1998) Curr Opin Cell Biol , vol.10 , pp. 123-130
    • Jordan, M.A.1    Wilson, L.2
  • 16
    • 33644520595 scopus 로고    scopus 로고
    • Systematic review of systemic therapy for advanced or recurrent endometrial cancer
    • Carey MS, Gawlik C, Fung-Kee-Fung M, Chambers A, Oliver T. Systematic review of systemic therapy for advanced or recurrent endometrial cancer. Gynecol Oncol 2006;101:158-67.
    • (2006) Gynecol Oncol , vol.101 , pp. 158-167
    • Carey, M.S.1    Gawlik, C.2    Fung-Kee-Fung, M.3    Chambers, A.4    Oliver, T.5
  • 17
    • 33646934663 scopus 로고    scopus 로고
    • Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies
    • Gadducci A, Cosio S, Genazzani AR. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: hormonal therapy, chemotherapy and molecularly targeted therapies. Crit Rev Oncol Hematol 2006;58:242-56.
    • (2006) Crit Rev Oncol Hematol , vol.58 , pp. 242-256
    • Gadducci, A.1    Cosio, S.2    Genazzani, A.R.3
  • 18
    • 0037365456 scopus 로고    scopus 로고
    • Endometrial cancer: Experimental models useful for studies on molecular aspects of endometrial cancer and carcinogenesis
    • Vollmer G. Endometrial cancer: experimental models useful for studies on molecular aspects of endometrial cancer and carcinogenesis. Endocr Relat Cancer 2003;10:23-42.
    • (2003) Endocr Relat Cancer , vol.10 , pp. 23-42
    • Vollmer, G.1
  • 19
    • 33747597588 scopus 로고    scopus 로고
    • Endometrial cancer cells as models to study uterine receptivity
    • Kuramoto H, Nishida M, editors, Tokyo:Springer-Verlag
    • Lessey BA, Vendrov AE, Yuan L. Endometrial cancer cells as models to study uterine receptivity. In: Kuramoto H, Nishida M, editors. Cell and molcular biology of endometrial carcinoma. Tokyo:Springer-Verlag, 2003.267-79.
    • (2003) Cell and molcular biology of endometrial carcinoma , pp. 267-279
    • Lessey, B.A.1    Vendrov, A.E.2    Yuan, L.3
  • 20
    • 0343415646 scopus 로고    scopus 로고
    • Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay
    • Bieche I, Nogues C, Paradis V, Olivi M, Bedossa P, Lidereau R, Vidaud M. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000;6:452-9.
    • (2000) Clin Cancer Res , vol.6 , pp. 452-459
    • Bieche, I.1    Nogues, C.2    Paradis, V.3    Olivi, M.4    Bedossa, P.5    Lidereau, R.6    Vidaud, M.7
  • 21
    • 0021118703 scopus 로고
    • Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
    • Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27-55.
    • (1984) Adv Enzyme Regul , vol.22 , pp. 27-55
    • Chou, T.C.1    Talalay, P.2
  • 23
    • 0035312747 scopus 로고    scopus 로고
    • Regulation of translation initiation by FRAP/mTOR
    • Gingras AC, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev 2001;15:807-26.
    • (2001) Genes Dev , vol.15 , pp. 807-826
    • Gingras, A.C.1    Raught, B.2    Sonenberg, N.3
  • 24
    • 0028197298 scopus 로고
    • Dominant negative mutants of mammalian translation initiation factor eIF-4A define a critical role for eIF-4F in cap-dependent and capin-dependent initiation of translation
    • Pause A, Methot N, Svitkin Y, Merrick WC, Sonenberg N. Dominant negative mutants of mammalian translation initiation factor eIF-4A define a critical role for eIF-4F in cap-dependent and capin-dependent initiation of translation. Embo J 1994;13:1205-15.
    • (1994) Embo J , vol.13 , pp. 1205-1215
    • Pause, A.1    Methot, N.2    Svitkin, Y.3    Merrick, W.C.4    Sonenberg, N.5
  • 25
    • 0141996464 scopus 로고    scopus 로고
    • Microtubules, microtubule-interfering agents and apoptosis
    • Mollinedo F, Gajate C. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 2003;8:413-50.
    • (2003) Apoptosis , vol.8 , pp. 413-450
    • Mollinedo, F.1    Gajate, C.2
  • 26
    • 43749116022 scopus 로고    scopus 로고
    • Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines
    • Aissat N, Le Tourneau C, Ghoul A, Serova M, Bieche I, Lokiec F, Raymond E, Faivre S. Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines. Cancer Chemother Pharmacol 2008;62:305-13.
    • (2008) Cancer Chemother Pharmacol , vol.62 , pp. 305-313
    • Aissat, N.1    Le Tourneau, C.2    Ghoul, A.3    Serova, M.4    Bieche, I.5    Lokiec, F.6    Raymond, E.7    Faivre, S.8
  • 27
    • 7944223834 scopus 로고    scopus 로고
    • Targeting the mammalian target of rapamycin (mTOR): A new approach to treating cancer
    • Chan S. Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer. Br J Cancer 2004;91:1420-4.
    • (2004) Br J Cancer , vol.91 , pp. 1420-1424
    • Chan, S.1
  • 28
    • 0037473081 scopus 로고    scopus 로고
    • Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosis
    • Le XF, Hittelman WN, Liu J, McWatters A, Li C, Mills GB, Bast RC, Jr. Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosis. Oncogene 2003;22:484-97.
    • (2003) Oncogene , vol.22 , pp. 484-497
    • XF, L.1    Hittelman, W.N.2    Liu, J.3    McWatters, A.4    Li, C.5    Mills, G.B.6    Bast Jr, R.C.7
  • 29
    • 0029902281 scopus 로고    scopus 로고
    • p70 S6 kinase sensitivity to rapamycin is eliminated by amino acid substitution of Thr229
    • Sugiyama H, Papst P, Gelfand EW, Terada N. p70 S6 kinase sensitivity to rapamycin is eliminated by amino acid substitution of Thr229. J Immunol 1996;157:656-60.
    • (1996) J Immunol , vol.157 , pp. 656-660
    • Sugiyama, H.1    Papst, P.2    Gelfand, E.W.3    Terada, N.4
  • 30
    • 32644476664 scopus 로고    scopus 로고
    • Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest
    • Bae-Jump VL, Zhou C, Gehrig PA, Whang YE, Boggess JF. Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest. Gynecol Oncol 2006;100:487-94.
    • (2006) Gynecol Oncol , vol.100 , pp. 487-494
    • Bae-Jump, V.L.1    Zhou, C.2    Gehrig, P.A.3    Whang, Y.E.4    Boggess, J.F.5
  • 31
    • 0035859956 scopus 로고    scopus 로고
    • p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD
    • Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci USA 2001;98:9666-70.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 9666-9670
    • Harada, H.1    Andersen, J.S.2    Mann, M.3    Terada, N.4    Korsmeyer, S.J.5
  • 35
    • 0037308546 scopus 로고    scopus 로고
    • Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach
    • Mo Y, Gan Y, Song S, Johnston J, Xiao X, Wientjes MG, Au JL. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. Cancer Res 2003;63:579-85.
    • (2003) Cancer Res , vol.63 , pp. 579-585
    • Mo, Y.1    Gan, Y.2    Song, S.3    Johnston, J.4    Xiao, X.5    Wientjes, M.G.6    Au, J.L.7
  • 36
    • 0032614548 scopus 로고    scopus 로고
    • Cell-killing by paclitaxel in a metastatic murine melanoma cell line is mediated by extensive telomere erosion with no decrease in telomerase activity
    • Multani AS, Li C, Ozen M, Imam AS, Wallace S, Pathak S. Cell-killing by paclitaxel in a metastatic murine melanoma cell line is mediated by extensive telomere erosion with no decrease in telomerase activity. Oncol Rep 1999;6:39-44.
    • (1999) Oncol Rep , vol.6 , pp. 39-44
    • Multani, A.S.1    Li, C.2    Ozen, M.3    Imam, A.S.4    Wallace, S.5    Pathak, S.6
  • 39
    • 35948965312 scopus 로고    scopus 로고
    • Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines
    • Catalano MG, Poli R, Pugliese M, Fortunati N, Boccuzzi G. Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines. Endocr Relat Cancer 2007;14:839-45.
    • (2007) Endocr Relat Cancer , vol.14 , pp. 839-845
    • Catalano, M.G.1    Poli, R.2    Pugliese, M.3    Fortunati, N.4    Boccuzzi, G.5
  • 42
    • 6344256753 scopus 로고    scopus 로고
    • mTOR: A protein kinase switching between life and death
    • Asnaghi L, Bruno P, Priulla M, Nicolin A. mTOR: a protein kinase switching between life and death. Pharmacol Res 2004;50:545-9.
    • (2004) Pharmacol Res , vol.50 , pp. 545-549
    • Asnaghi, L.1    Bruno, P.2    Priulla, M.3    Nicolin, A.4
  • 43
    • 46149092748 scopus 로고    scopus 로고
    • Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
    • Jiang BH, Liu LZ. Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. Drug Resist Updat 2008;11:63-76.
    • (2008) Drug Resist Updat , vol.11 , pp. 63-76
    • Jiang, B.H.1    Liu, L.Z.2
  • 44
    • 12344288380 scopus 로고    scopus 로고
    • Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin
    • VanderWeele DJ, Zhou R, Rudin CM. Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin. Mol Cancer Ther 2004;3:1605-13.
    • (2004) Mol Cancer Ther , vol.3 , pp. 1605-1613
    • VanderWeele, D.J.1    Zhou, R.2    Rudin, C.M.3
  • 45
    • 69249085764 scopus 로고    scopus 로고
    • Synergistic effect of rapamycin and cisplatin in endometrial cancer cells
    • Bae-Jump VL, Zhou C, Boggess JF, Gehrig PA. Synergistic effect of rapamycin and cisplatin in endometrial cancer cells. Cancer 2009; 115:3887-96.
    • (2009) Cancer , vol.115 , pp. 3887-3896
    • Bae-Jump, V.L.1    Zhou, C.2    Boggess, J.F.3    Gehrig, P.A.4
  • 46
    • 4444346646 scopus 로고    scopus 로고
    • AKT involvement in cisplatin chemoresistance of human uterine cancer cells
    • Gagnon V, Mathieu I, Sexton E, Leblanc K, Asselin E. AKT involvement in cisplatin chemoresistance of human uterine cancer cells. Gynecol Oncol 2004;94:785-95.
    • (2004) Gynecol Oncol , vol.94 , pp. 785-795
    • Gagnon, V.1    Mathieu, I.2    Sexton, E.3    Leblanc, K.4    Asselin, E.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.